Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term oral lacosamide follow-up in pediatric epilepsy (EP0034/SP848 completers)
2020-001478-30Phase 3Active
- Sponsor
- UCB
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of lacosamide in epilepsy, sponsored by UCB. Started Aug 2020; status: active.
02
Drugs
lacosamide
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2020-001478-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001478-30.